Investing in the Brain: a Generalist Investor Guide to Spotting Winning Neurotech Startups
<p>The blueprint for a stellar neurotech company remains a puzzle. Investors have not yet established quantifiable methods of evaluating neurotech companies comparable to those applied in other industries. For example, companies operating in the software as a service (SaaS) market can rely on what is known as ‘<a href="https://medium.com/point-nine-news/what-does-it-take-to-raise-capital-in-saas-in-2023-56d8f617714" rel="noopener">SaaS napkins</a>’, a collection of metrics that a company should hit to be considered by venture capitalists (VCs). Building companies and raising capital are particularly challenging in the absence of a consensus on criteria and metrics for what constitutes success — or at least the promise of it.</p>
<p><a href="https://medium.com/neurotechx/investing-in-the-brain-a-generalist-investor-guide-to-spotting-winning-neurotech-startups-3f29624a0586"><strong>Website</strong></a></p>